| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0304-3835(96)04161-4 |
| P698 | PubMed publication ID | 8603372 |
| P2093 | author name string | G J Pilkington | |
| S Koochekpour | |||
| A Merzak | |||
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 209-215 | |
| P577 | publication date | 1996-04-01 | |
| P1433 | published in | Cancer Letters | Q326372 |
| P1476 | title | Vascular endothelial growth factor production is stimulated by gangliosides and TGF-beta isoforms in human glioma cells in vitro | |
| P478 | volume | 102 |
| Q34524965 | A glycobiology review: carbohydrates, lectins and implications in cancer therapeutics |
| Q30455596 | Angiogenic inhibition in high-grade gliomas: past, present and future |
| Q35104246 | Anti-angiogenic agents for the treatment of brain tumors |
| Q34120472 | Antibody-based immunotherapy for malignant glioma |
| Q48836069 | Assessment of the molecular expression and structure of gangliosides in brain metastasis of lung adenocarcinoma by an advanced approach based on fully automated chip-nanoelectrospray mass spectrometry. |
| Q45873481 | Blockade of TGF-beta by in vivo gene transfer of a soluble TGF-beta type II receptor in the muscle inhibits corneal opacification, edema and angiogenesis |
| Q47753606 | Cholera Toxin Subunit B Enabled Multifunctional Glioma-Targeted Drug Delivery |
| Q37179415 | Combating immunosuppression in glioma |
| Q31013320 | Combining cytotoxic and immune-mediated gene therapy to treat brain tumors |
| Q36276111 | Diabetes alters sphingolipid metabolism in the retina: a potential mechanism of cell death in diabetic retinopathy |
| Q38962204 | Differential regulation of TGF-β-induced, ALK-5-mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastoma |
| Q43097972 | Differential uPAR recruitment in caveolar-lipid rafts by GM1 and GM3 gangliosides regulates endothelial progenitor cells angiogenesis |
| Q33718137 | Diverse roles of the vasculature within the neural stem cell niche |
| Q79249973 | Effect of neoadjuvant chemoradiotherapy on angiogenesis in oesophageal cancer |
| Q36489766 | Extracellular angiogenic growth factor interactions: an angiogenesis interactome survey |
| Q35047170 | GD3 ganglioside and apoptosis |
| Q35019480 | GD3 in cellular ageing and apoptosis. |
| Q91670656 | Ganglioside GD3 synthase (GD3S), a novel cancer drug target |
| Q34178829 | Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs |
| Q40140251 | Hepatocyte growth factor production is stimulated by gangliosides and TGF-beta isoforms in human glioma cells |
| Q77530408 | Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia |
| Q34457421 | Inhibition of vascular endothelial growth factor in the treatment of solid tumors |
| Q38328525 | Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures |
| Q35476365 | Intrathecal inflammation precedes development of Alzheimer's disease |
| Q34136498 | Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape |
| Q36429021 | Mechanisms of angiogenesis in gliomas |
| Q34566436 | Migration and invasion in brain neoplasms |
| Q26830588 | Molecular recognition of gangliosides and their potential for cancer immunotherapies |
| Q77995177 | Peripheral blood mononuclear cells from patients with rheumatoid arthritis spontaneously secrete vascular endothelial growth factor (VEGF): specific up-regulation by tumour necrosis factor-alpha (TNF-alpha) in synovial fluid |
| Q40080387 | Progenitor/Stem Cell Markers in Brain Adjacent to Glioblastoma: GD3 Ganglioside and NG2 Proteoglycan Expression |
| Q53383082 | Promotion of stem cell proliferation by vegetable peptone. |
| Q40858529 | Reduced cell migration, tumor growth and experimental metastasis of rat F-11 cells whose expression of GD3-synthase is suppressed |
| Q48032967 | Reduced cerebral vascularization in experimental neuronopathic Gaucher disease. |
| Q43777828 | Role of AP-1 and HIF-1 transcription factors in TGF-beta activation of VEGF expression |
| Q35138120 | Role of tumor-associated gangliosides in cancer progression |
| Q38195691 | Sphingolipids: key regulators of apoptosis and pivotal players in cancer drug resistance |
| Q38008966 | The molecular profile of microglia under the influence of glioma |
| Q56658816 | Thematic Review Series: Sphingolipids.Ganglioside GM3 suppresses the proangiogenic effects of vascular endothelial growth factor and ganglioside GD1a |
| Q36558306 | Thematic review series: sphingolipids. Ganglioside GM3 suppresses the proangiogenic effects of vascular endothelial growth factor and ganglioside GD1a |
| Q37493413 | Therapeutic targets in malignant glioblastoma microenvironment |
| Q43846990 | Transforming growth factor beta induces vascular endothelial growth factor elaboration from pleural mesothelial cells in vivo and in vitro |
| Q41489951 | Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity |
| Q35042985 | Trimodal glioblastoma treatment consisting of concurrent radiotherapy, temozolomide, and the novel TGF-β receptor I kinase inhibitor LY2109761. |
| Q41062315 | Tumor-associated macrophages in glioma: friend or foe? |
Search more.